Supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease’s statin therapy in me

Not Applicable

Completed

• Conditions: on- alcoholic fatty liver disease (NAFLD)

• Registration Number: TCTR20180425001
• Lead Sponsor: Ss. Cyril and Methodius University in Skopje

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-12-31
• Study Start: 2018-04-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 74

Inclusion Criteria

Patients were required to have hepatorenal contrast and liver brightness according to the scoring system by doi:10.1111/j.1572-0241.2007.01526.x

Exclusion Criteria

Patients were excluded if they had any other chronic liver disease, malignancy or inflammatory disease.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ormalization of the activity of antioxidant enzymes At the end of the intervention Enzyme activity

Secondary Outcome Measures

Name	Time	Method
ormalization of the serum lipid profile At the end of the intervention Concentration in serum,Normalization of the aminotransferase levels At the end of the intervention Activity in serum,Normalization of CRP levels At the end of the intervention Concentration in serum